{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T08:04:42Z","timestamp":1649145882475},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,15]]},"DOI":"10.1093\/infdis\/jir183","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T04:32:22Z","timestamp":1306211542000},"page":"1875-1875","source":"Crossref","is-referenced-by-count":0,"title":["Regarding \u201cType 2 Vaccine-Derived Poliovirus From Patients With Acute Flaccid Paralysis in China: Current Immunization Strategy Effectively Prevented Its Sustained Transmission\u201d"],"prefix":"10.1093","volume":"203","author":[{"given":"Subhash C.","family":"Arya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmala","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"key":"key\n\t\t\t\t20170511120452_bib1","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1086\/657410","article-title":"Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in China: current immunization strategy effectively prevented its sustained transmission","volume":"202","author":"Zhang","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170511120452_bib2","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.pone.0000069","article-title":"Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations","volume":"1","author":"Shulman","year":"2006","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170511120452_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1126\/science.324.5925.334b","article-title":"Type 2 polio still in our midst","volume":"324","author":"Shulman","year":"2009","journal-title":"Science"},{"key":"key\n\t\t\t\t20170511120452_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.305.6845.79","article-title":"Paralytic poliomyelitis in England and Wales","volume":"305","author":"Joce","year":"1992","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170511120452_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pbc.21277","article-title":"Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients","volume":"49","author":"Yu","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20170511120452_bib6","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/203\/12\/1875\/11650384\/jir183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T12:22:39Z","timestamp":1503490959000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jir183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":6,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,6,15]]},"published-print":{"date-parts":[[2011,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jir183","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,15]]}}}